What are the core technical differences between BLI and SPR for screening antibody binding? A Detailed Guide

The key difference lies in the optical principle and sample handling.
Biolayer Interferometry (BLI) detects binding by measuring the shift in an interference pattern of white light reflected from a biosensor tip, using a dip‑and‑read format with disposable probes and no microfluidics. Surface Plasmon Resonance (SPR) detects binding by measuring tiny changes in the angle of total internal reflection on a gold‑coated sensor chip, using microfluidic flow channels and regenerable surfaces. While both deliver real‑time, label‑free data, BLI excels at rapid, high‑throughput screening, and SPR provides superior sensitivity and resolution for detailed kinetic analysis.

The core trade‑off is simplicity vs. depth. BLI’s microfluidic‑free, plug‑and‑play design accelerates screening and reduces clogging risk, but at the cost of lower sensitivity and a disposable sensor model. SPR’s flow‑cell architecture yields exquisite kinetic data and reusable chips, yet demands more setup, regeneration, and time.

The Detection Principle: What Each Instrument Actually Measures

SPR: Measuring a Shift in the Evanescent Field

SPR monitors changes in the angle of total internal reflection of light on a thin gold film. When molecules bind to the sensor surface, the local refractive index changes, shifting the resonance angle. This shift is proportional to the mass accumulating on the chip, allowing real‑time monitoring of association and dissociation. The gold surface is typically coated with a dextran matrix to reduce non‑specific binding and provide a flexible chemistry for ligand immobilization.

BLI: Measuring Interference Pattern Shifts

BLI uses a biosensor tip with a biocompatible layer on an optical fiber. White light travels down the fiber, and two reflections—from an internal reference layer and the tip‑solution interface—create a characteristic interference pattern. Binding of molecules to the tip changes the optical path length, resulting in a wavelength shift in the interference pattern that is measured in real time. This elegant, microfluidic‑free design eliminates pumps and flow cells.

Sample Handling and Throughput: Microfluidics vs. Dip‑and‑Read

SPR’s Microfluidic Flow Channels

SPR instruments push samples and buffer through narrow flow cells over the sensor surface. This controlled flow provides precise mass transport, enabling accurate determination of association and dissociation rate constants (kₒₙ, kₒff). However, the fluidics require maintenance, are susceptible to clogging with complex samples, and rely on consistent flow rates for reproducible data.

BLI’s Dip‑and‑Read Simplicity

BLI simply immerses disposable biosensor probes directly into a microplate well containing the sample. The probes oscillate vertically, and binding occurs from a static solution—no flow, no tubing. This design virtually eliminates clogging risks and permits parallel processing of 8 to 12 probes simultaneously, dramatically shortening the time to screen a large panel of antibodies or conditions.

Impact on Screening Throughput

Because BLI bypasses fluidic setup and washing steps, assay development is rapid—a quick concentration measurement can be done in under 3 minutes once probes are hydrated. In a screening context, this means dozens of antibody‑antigen pairs can be ranked in a single run. SPR, while capable of running multiple cycles, generally requires longer between runs for surface regeneration and re‑equilibration.

Sensor Reusability and Cost

SPR Chip Regeneration

A significant practical advantage of SPR is that a single sensor chip can be regenerated and reused 20–30 times. This amortizes the chip cost over many experiments and allows consistent surface chemistry across a series of measurements. However, regeneration conditions must be carefully optimized to strip analyte without damaging the immobilized ligand, and repeated cycles can gradually degrade performance.

BLI’s Single‑Use Probes

BLI uses disposable, one‑use biosensor tips. There is no regeneration step; each new interaction uses a fresh tip. This avoids regeneration‑related artifacts and simplifies experimental design, but it makes probe cost per data point a key factor when scaling up large screening campaigns.

Sensitivity and Data Depth: Kinetics vs. Rapid Quantitation

SPR: The Gold Standard for Detailed Kinetics

Thanks to the continuous‑flow design and a highly sensitive evanescent field, SPR can detect low‑affinity and small‑analyte interactions with high signal‑to‑noise. It reliably extracts full kinetic rate constants (kₒₙ, kₒff) and equilibrium dissociation constants (K_D) from multi‑concentration injections. For applications demanding mechanistic understanding—such as characterizing slow off‑rates or comparing closely related antibody variants—SPR remains the benchmark.

BLI: Speed for Concentration Ranking and Early Screening

BLI often has a higher limit of detection compared to SPR, making it less suitable for quantifying very weak interactions or extremely small analytes. Its strength is fast, parallel ranking: crude antibody supernatants or purified samples can be assessed head‑to‑head to quickly identify hits with favorable binding profiles. Concentration measurements (e.g., quantifying antibody titer via a standard curve) are particularly fast because only a few minutes of binding suffice to extract a reliable endpoint.

Understanding the Trade‑offs

No single platform is universally superior; each choice involves meaningful compromises.

• BLI sacrifices ultimate sensitivity for speed and simplicity. Detection limits are typically higher, and extracting precise off‑rate constants can be challenging if the binding signal decays slowly and the dip‑and‑read format suffers from lower mass transport. Disposable tip cost must be weighed against the elimination of fluidic maintenance.
• SPR demands more hands‑on time and is more prone to clogging and assay drift. While it delivers gold‑standard kinetic data, a screening campaign may progress more slowly, and method development for regeneration can be a bottleneck. The reusable chip model, though cost‑efficient per cycle, requires careful tracking of surface integrity.

How to Apply This to Your Screening Workflow

• If your primary focus is high‑throughput early‑stage antibody screening: Choose BLI for its parallel “dip‑and‑read” format and minimal assay setup time; you can rapidly bin hits without worrying about fluidics.
• If your primary focus is detailed kinetic characterization of a small number of lead candidates: Turn to SPR to extract reliable kₒₙ, kₒff, and K_D values, and to resolve subtle affinity differences that inform lead optimization.
• If your primary focus is quantifying protein titer or ranking binders from crude samples: BLI’s speed and tolerance for complex matrices (no clogging) make it a strong candidate.
• If your primary focus is long‑term cost efficiency for repeated kinetic runs on a stable ligand: SPR’s regenerable sensor chips can offer a lower cost per experiment once the method is established.

By aligning the choice with the true experimental goal—speed and simplicity versus kinetic depth—you ensure the right tool drives your decision‑making, not the tool driving your workflow.

Summary Table:

Whether you are optimizing antibody binding assays or developing cutting-edge diagnostic workflows, CamelBio provides diagnostic manufacturers, labs, and research institutes with one-stop access to premium IVD raw materials, technical services, and consulting—covering every stage from concept to clinic.

Streamline your assay performance and accelerate your path to clinic—contact CamelBio today to speak with our technical team!